Inactivated Polio Vaccine (IPV) dominates in revenue and adopts the preferred safety profile, while Oral Polio Vaccine (OPV)—especially novel nOPV2—grows fastest due to mass immunization use https://www.datamintelligence.com/research-report/polio-vaccine-market